Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole Alone vs Letrozole + Estradiol Valerate in PMOS
NCT07379502Completed
- Sponsor
- CMH Kharian Medical College
- Start
- Mar 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of estradiol valerate in Polycystic Ovary Syndrome (PCOS) (2 arms), sponsored by CMH Kharian Medical College. Primary endpoints: Endometrial thickness at 12 days and Pattern of endometrium at 12 days. Started Mar 2026; status: completed.
02
Drugs
estradiol valerate
03
Conditions
Polycystic Ovary Syndrome (PCOS)
Beyond the preview
Go deeper on NCT07379502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07379502.